Uppsala

• A prospective phase II study to assess the minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for … Ended recruitment
  2024-517321-99-00 4 2016-08-01 Myeloma multiplex
• PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers … Ended recruitment
  2024-514841-12-00 5 2015-10-27 To determine whether the addition of palbociclib to adjuvant endocrine
• An international study to evaluate the safety and effectiveness of enzalutamide plus leuprolide, enzalutamide alone, and leuprolide alone in … Ended recruitment
  2024-513521-23-00 5 2015-08-19 Prostate Cancer
• PREDIX HER2 - preoperative treatment of HER2 positive breast cancer Ended recruitment
  2023-508411-23-00 4 2014-11-12 Primary breast cancer
• A phase 3, randomised, double-blind, placebo-controlled, parallel-arm efficacy trial of Imatinib in acute ischaemic stroke Halted
  2023-506178-11-00 5 2025-11-11 Acute ischemic stroke
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-6404 … Halted
  2023-505096-68-00 4 2025-01-14 Preclinical Alzheimer’s Disease
• A phase 1, randomized, double-blind, single-center, placebo-controlled first-in-human trial to assess the safety, tolerability, pharmacokine … Halted
  2023-510371-55-00 1 2024-11-14 Complement-mediated diseases
• CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind … Halted
  2023-505532-35-00 4 2024-05-15 Major Depressive Disorder
• A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine … Halted
  2023-504215-32-00 9 2023-09-28 Overweight and obesity
• A randomized, three-period, single-dose crossover trial in healthy female volunteers to demonstrate bioequivalence of tafoxiparin following … Ended
  2025-521140-38-00 2 2026-02-11 Labor priming
• An open-label, randomized, single-dose, three-way crossover trial to evaluate the pharmacokinetics of nicotine pouch (NP) dry 4 mg compared … Ended
  2025-523879-34-00 2 2025-11-17 Nicotine use
• An open, single arm, single-center, Phase 1 trial investigating the effect of 7-days-repeated administration of linaprazan glurate on the ph … Ended
  2024-518194-34-00 3 2025-11-11 Helicobacter pylori infection, GERD
• A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of … Ended
  2025-522287-32-00 3 2025-10-22 Depression
• Treatment of normal pressure hydrocephalus with acetazolamide Ended
  2024-514828-16-00 4 2025-09-25 Normal pressure hydrocephalus
• A prospective, double-blinded, randomized, placebo-controlled phase 1/2a study to assess safety, tolerability, systemic exposure and prelimi … Ended
  2024-517920-21-00 9 2025-08-19 knee osteoarthritis
• A randomised, open-label, 5-period, cross-over trial to assess the pharmacokinetics and safety of 3 oral solid formulations of buloxibutid ( … Ended
  2025-520702-35-00 3 2025-05-14 Idiopahtic pulmonary fibrosis
• A PilOt dose-escalation trial with EMP16 in preparation for Phase III – the POEM trial Ended
  2024-520122-11-00 4 2025-05-07 Obesity
• A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food … Ended
  2024-515078-28-00 3 2025-04-16 Diabetic Retinopathy
• A FIRST-IN-HUMAN PHASE I TRIAL OF OX118 IN HEALTHY VOLUNTEERS Ended
  2024-515378-28-00 1 2025-04-03 Immune system Diseases
• An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporo … Ended
  2024-514496-18-01 3 2025-01-30 Hepatocellular carcinoma, renal cell carcinoma and differentiated thyr
• An open-label, randomised, single-dose, three-way cross-over trial to assess the pharmacokinetics of NIC24-01 and NIC24-02 oromucosal pouche … Ended
  2024-514676-40-00 3 2024-12-12 Nicotine dependence
• Safety Trial, DSC vs. BAT in SR acute GvHD Ended
  2024-511768-97-01 4 2024-11-20 Graft vs Host Disease
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom … Ended
  2024-512848-30-00 4 2024-11-12 HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER
• A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erec … Ended
  2024-515065-34-00 4 2024-11-07 Erectile dysfunction (ED)

Showing 265–288 of 354 trials